Dose calculation quick reference For the 17 mg/mL concentration (most common Empower formulation): For precise calculations, the SeekPeptides peptide calculator handles the math automatically
Large study shows benefits and harms of GLP-1s in people with diabetes January 27, 2025 Source: Xie, et al, Nature Medicine, January 20, 2025 Researchers published a comprehensive review of electronic medical records from the Veterans Administration (VA) to demonstrate the benefits and harms of GLP-1 medications
Semaglutide and Tirzepatide work to promote weight loss by reducing appetite, increasing feelings of fullness, and slowing down stomach emptying
The combination of personalized guidance and community support helps members navigate the complexities of GLP-1 therapy with confidence
This increased convenience may translate to improved medication adherence, a crucial factor in achieving long-term weight loss and glycemic control